Safety Evaluation of Contezolid (MRX-I) Versus Linezolid in Sprague-Dawley Rats
Abstract Background & Objectives Contezolid (MRX-I) is a novel ortho-fluorophenyl dihydropyridone developed by MicuRx Pharmaceuticals, Inc. It has been approved for the treatment of drug-resistant Gram-positive bacterial infections with relatively lower toxicity than other oxazolidinones such as lin...
Zapisane w:
| Główni autorzy: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Adis, Springer Healthcare
2025-05-01
|
| Seria: | Drugs in R&D |
| Dostęp online: | https://doi.org/10.1007/s40268-025-00504-x |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|